Methods and reagents for diagnosing hantavirus infection
AssigneeNovartis Vaccines and Diagnostics, Inc.
InventorsSteve H. Nguyen, Sergio Pichuantes
Life of this patent
Estimating the term…
Abstract
Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.
Claims12
A method of detecting hantavirus antibodies in a biological sample, comprising:
- (a) contacting said biological sample with at least six hantavirus recombinant antigens, wherein the at least six hantavirus recombinant antigens comprise a combination of N antigens from hantavirus serotypes Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDY) wherein at least one recombinant antigen from each of the serotypes is present, said contacting performed under conditions which allow hantavirus antibodies, when present in the biological sample, to bind to at least one of said N antigens to form an antibody/antigen complex, and wherein said N antigens comprise one or more amino acid sequences selected from the group consisting of SEQ ID NO:28, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52 and SEQ ID NO:53;
- and
- (b) detecting the presence or absence of said antibody/antigen complex, thereby detecting the presence or absence of hantavirus antibodies in said sample.
An immunodiagnostic test kit for detecting hantavirus infection, said test kit comprising:
- (a) at least six hantavirus recombinant antigens, wherein the at least six hantavirus recombinant antigens comprise a combination of N antigens from hantavirus serotypes Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV) wherein at least one N antigen from each of the serotypes is present, and wherein said N antigens comprise one or more amino acid sequences selected from the group consisting of SEQ ID NO:28, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52 and SEQ ID NO:53;
- (b) and instructions for conducting the immunodiagnostic test.
A solid support comprising at least six hantavirus recombinant antigens, wherein the at least six hantavirus recombinant antigens comprise a combination of N antigens from hantavirus serotypes Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV) wherein at least one N antigen from each of the serotypes is present, and wherein said N antigens comprise one or more amino acid sequences selected from the group consisting of SEQ ID NO:28, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52 and SEQ ID NO:53.
An immunodiagnostic test kit for detecting hantavirus infection, said test kit comprising:
- (a) at least six hantavirus recombinant antigens, wherein the at least six hantavirus recombinant antigens comprise the amino acid sequences of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, and SEQ ID NO:36, respectively;
- (b) and instructions for conducting the immunodiagnostic test.
A solid support comprising at least six hantavirus recombinant antigens, wherein the at least six hantavirus recombinant antigens comprise the amino acid sequences of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, and SEQ ID NO:36, respectively.
Dependencies are inferred from the claim text.